Menu

Frédéric PERRAUD

Strasbourg

Electionseuropéennes 2024

RETROUVEZ GRATUITEMENTLe résultat des européennes à Strasbourg ainsi que le résultat des européennes dans le Bas-Rhin.

En résumé

Ph.D. in Molecular Biology from the University of Strasbourg and graduate from the IAE of Strasbourg, I began my career as scientist at Transgene, a French biotechnology company working in the field of gene therapy. From 1998 to 2001 I was a member of the board of Neurofit, a French clinical research organization (CRO) with a special focus on studies involving the central nervous system. I was Director of Finances and Human Resources at CareX a Start Up in the field of the obesity treatment for three years from 2002 to 2004. I joined Polyplus-Transfection as CFO in 2005 and was appointed CEO in February 2009 and COO and Deputy CEO .from 2010 to 2012. Consultant specialized in creation and development of biotech and techmed companies. Currently involved as CFO at Inoviem Scientific.

Mes compétences :
budgets
Due Diligence

Entreprises

  • Inoviem Scientific - CFO

    Strasbourg 2013 - maintenant

  • Inoviem Scientific - Directeur Administratif et Financier & Consultant

    Strasbourg 2013 - maintenant Inoviem Scientific propose des services d'identification de cibles thérapeutiques, de détermination du mode d'action d'un principe actif (effets thérapeutiques et effets secondaires) et de développement de biomarqueurs.
    Fonction :
    Directeur Administratif et Financier. Consultant. Support au développement stratégique et à la recherche de financements.

  • Polyplus-transfection - CFO. CEO. COO. Deputy CEO

    2005 - 2012

  • CareX - Directeur Finances et Ressources Humaines

    Massy 2002 - 2004 Achievements:
    -Contact with the SERS (landlord) and the builder of the new facilities, budget, building refurbishment.
    -Writing of all the relevant legal documentation.
    -Implementation of financial management system.
    -Involved in the Due Diligence Process for the 2nd financing round early 2004.
    -Grants. Taxe Credit.
    -Appraisal system, human resources.

    The company growth from 12 to 38 people and moved in a new building. Completion of the 2nd financing round (25 M€ february 2004).

  • Neurofit - Board member, Delegate as Director of Administration and Finance by the Board of Directors

    2001 - 2002 Achievements:
    -Significant cost reductions.
    -Development of a trade sale programme.
    -Implementation of financial management system, reporting and project cost system.

    The company transitioned from loss to profitability during my mission

  • Transgene - Senior Research Scientist

    Illkirch Graffenstaden Cedex 1988 - 2002 Production of Human recombinant Proteins in transgenic animals.(1988-1995)
    Head of the Histology Group (1991-1999)
    Gene Therapy of Duchenne Muscular Dystrophy(1995-1999)
    Multiple Sclerosis Gene therapy (2000-2002)
    23 publications and 3 patents

Formations

Pas de formation renseignée

Réseau

Annuaire des membres :